Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

414 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice.
Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. Matsuzaki T, et al. Among authors: yamazaki r. J Dairy Sci. 1998 Jan;81(1):48-53. doi: 10.3168/jds.S0022-0302(98)75549-3. J Dairy Sci. 1998. PMID: 9493081
Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice.
Yamazaki R, Aiyama R, Matsuzaki T, Hashimoto S, Yokokura T. Yamazaki R, et al. Inflamm Res. 1998 Apr;47(4):182-6. doi: 10.1007/s000110050315. Inflamm Res. 1998. PMID: 9628261
Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice.
Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. Matsuzaki T, et al. Among authors: yamazaki r. Endocr J. 1997 Jun;44(3):357-65. doi: 10.1507/endocrj.44.357. Endocr J. 1997. PMID: 9279510
Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors.
Yamazaki R, Kawai S, Matsuzaki T, Kaneda N, Hashimoto S, Yokokura T, Okamoto R, Koshino T, Mizushima Y. Yamazaki R, et al. Eur J Pharmacol. 1997 Jun 25;329(2-3):181-7. Eur J Pharmacol. 1997. PMID: 9226412
Diarylheptanoids suppress expression of leukocyte adhesion molecules on human vascular endothelial cells.
Yamazaki R, Hatano H, Aiyama R, Matsuzaki T, Hashimoto S, Yokokura T. Yamazaki R, et al. Eur J Pharmacol. 2000 Sep 22;404(3):375-85. doi: 10.1016/s0014-2999(00)00620-8. Eur J Pharmacol. 2000. PMID: 10996603
A major metabolite of aceclofenac, 4'-hydroxy aceclofenac, suppresses the production of interstitial pro-collagenase/proMMP-1 and pro-stromelysin-1/proMMP-3 by human rheumatoid synovial cells.
Yamazaki R, Kawai S, Mizushima Y, Matsuzaki T, Hashimoto S, Yokokura T, Ito A. Yamazaki R, et al. Inflamm Res. 2000 Mar;49(3):133-8. doi: 10.1007/s000110050571. Inflamm Res. 2000. PMID: 10807502
Development of a novel method for determination of acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase activity and its application to screening for acetyltransferase inhibitors. Inhibition by magnolol and honokiol from Magnoliae cortex.
Yamazaki R, Sugatani J, Fujii I, Kuroyanagi M, Umehara K, Ueno A, Suzuki Y, Miwa M. Yamazaki R, et al. Biochem Pharmacol. 1994 Mar 15;47(6):995-1006. doi: 10.1016/0006-2952(94)90410-3. Biochem Pharmacol. 1994. PMID: 8147919
4'-Hydroxy aceclofenac suppresses the interleukin-1-induced production of promatrix metalloproteinases and release of sulfated-glycosaminoglycans from rabbit articular chondrocytes.
Akimoto H, Yamazaki R, Hashimoto S, Sato T, Ito A. Akimoto H, et al. Among authors: yamazaki r. Eur J Pharmacol. 2000 Aug 11;401(3):429-36. doi: 10.1016/s0014-2999(00)00472-6. Eur J Pharmacol. 2000. PMID: 10936503
Multidirectional contraction of human hypertrophied prostate.
Moriyama N, Miyata N, Yamaura H, Yamazaki R, Tsuchida K, Kurimoto S, Nagase Y, Ishida Y, Kawabe K. Moriyama N, et al. Among authors: yamazaki r. Gen Pharmacol. 1994 Nov;25(7):1459-64. doi: 10.1016/0306-3623(94)90174-0. Gen Pharmacol. 1994. PMID: 7534738
Hydrolytic activity is essential for aceclofenac to inhibit cyclooxygenase in rheumatoid synovial cells.
Yamazaki R, Kawai S, Matsumoto T, Matsuzaki T, Hashimoto S, Yokokura T, Okamoto R, Koshino T, Mizushima Y. Yamazaki R, et al. J Pharmacol Exp Ther. 1999 May;289(2):676-81. J Pharmacol Exp Ther. 1999. PMID: 10215639
414 results
Jump to page
Feedback